Akeso ivonescimab zeigt Überlebensvorteil bei Lungenkrebs

Kirla Web-ServicesFocused web services and digital products.

Cookie settings for Kirla Chronicle

We use technically necessary cookies and security services for sign-in, session protection, and abuse prevention. Optional categories (preferences, external services, analytics, marketing) can be allowed or rejected now and changed later at any time.

Akeso ivonescimab zeigt Überlebensvorteil bei Lungenkrebs — ASCO26-Studienergebnisse